Posts Tagged pharma blog
I’m a bit late with this post as February’s PME (Pharmaceutical Market Europe) has been out for a while now. Once again the magazine features the latest print outing for my Digital Intelligence blog.
It asks, after the MHRA approves its first app, whether pharma mobile apps are medical devices. There’s also room for a look at the FDA’s ‘social media’ guidance on off-label information requests, a real-world evidence collaboration between AstraZeneca and IMS Health and much more.
• Read February’s PME in full online
January’s PME (Pharmaceutical Market Europe) is out now and with it the second print outing for my Digital Intelligence blog.
Leading with a European slant on the NHS telehealth pilot, it takes in Novartis’ CEO on using technology to improve healthcare access and a Manhattan Research study on Europeans and online health information.
There’s room too for a new health technology partnership from GE Healthcare (whose CEO and president I also happened to interview for this issue of PME), an exclusive on the first official Google+ pages from pharma and much more.